Expression of FasL in Proliferation of Retinoblastoma Cells: A Mechanism Fas Counterattack -
作者： Hendrian Dwikoloso Soebagjo , Hidayat Sujuti , Hasan Machfoed , Sutiman Bambang Soemitro , None
DOI:
关键词: Chemistry 、 Immunohistochemistry 、 Cancer research 、 Protein expression 、 Fas ligand 、 Paraffin Block 、 Retinoblastoma
摘要: Purpose: The aim of this study were to determine the association increasing FasL with proliferation retinoblastoma cells. Materials and Methods: protein expression was analyzed in 30 samples from paraffin block using immunohistochemical method for evaluation FasL, CDK4, Ki-67 expression. Results: Among samples, majority negative 33.3 % (10 samples) strong 36,8 (11 samples). CDK4 53,3% weak high also (16 significantly related (r: 0.363; p: 0.048). 0.601; 0.000). Conclusion: on mechanism Fas counterattack induces cells.
unair.ac.id参考文章(30)
Qiang-Song Tong, Shi-Wang Li, Qing-Lan Ruan, Guo-Song Jiang, Shao-Tao Tang, Li-Duan Zheng, Jia-Bin Cai, Yuan Liu, Expression of Fas and FasL in human neuroblastoma and its clinical significance ,(2007)
I Sporea, A Goldiş, Corina Vernic, Elena Lazăr, Alis Dema, Sorina Tăban, Daniela Lazăr, Mărioara Cornianu, Ki-67 expression in gastric cancer. Results from a prospective study with long-term follow-up Romanian Journal of Morphology and Embryology. ,vol. 51, pp. 655- 661 ,(2010)
Marc Diederich, Natural compounds and their role in apoptotic cell signaling pathways Blackwell Pub. on behalf of the New York Academy of Sciences. ,(2009)
Nicholas Mitsiades, Vassiliki Poulaki, Maria Tsokos, Wei-hsuan Yu, Ivan Stamenkovic, Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. Cancer Research. ,vol. 61, pp. 577- 581 ,(2001)
Young Bok Lee, Eun Kyung Kim, Hyun Jeong Park, Baik Kee Cho, Young Min Park, Jin Woo Kim, Nam Jin Yoo, Yong Gyu Park, Shin Taek Oh, Expression of Fas and Fas ligand in primary cutaneous squamous cell carcinoma in association with grade of tumor differentiation. International Journal of Dermatology. ,vol. 52, pp. 1092- 1097 ,(2013) , 10.1111/J.1365-4632.2012.05525.X
Ander Urruticoechea, Ian E. Smith, Mitch Dowsett, Proliferation Marker Ki-67 in Early Breast Cancer Journal of Clinical Oncology. ,vol. 23, pp. 7212- 7220 ,(2005) , 10.1200/JCO.2005.07.501
Subramanian Krishnakumar, Mallikarjuna Kandalam, Adithi Mohan, Anita Iyer, Nalini Venkatesan, Jyotirmay Biswas, Mahesh Palanivelu Shanmugam, None, Expression of Fas ligand in retinoblastoma Cancer. ,vol. 101, pp. 1672- 1676 ,(2004) , 10.1002/CNCR.20533
Masato Tanaka, Toshimitsu Itai, Masashi Adachi, Shigekazu Nagata, Downregulation of Fas ligand by shedding Nature Medicine. ,vol. 4, pp. 31- 36 ,(1998) , 10.1038/NM0198-031
Makoto Shimizu, Masashi Kondo, Yasushi Ito, Hiroaki Kume, Ryujiro Suzuki, Kenichi Yamaki, Soluble Fas and Fas ligand provide new information on metastasis and response to chemotherapy in SCLC patients. Cancer Detection and Prevention. ,vol. 29, pp. 175- 180 ,(2005) , 10.1016/J.CDP.2004.09.001
O Ben-Izhak, M Bar-Chana, L Sussman, V Dobiner, J Sandbank, M Cagnano, H Cohen, E Sabo, Ki67 antigen and PCNA proliferation markers predict survival in anorectal malignant melanoma. Histopathology. ,vol. 41, pp. 519- 525 ,(2002) , 10.1046/J.1365-2559.2002.01444.X